This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Wim Bert Griet Schepens
Introduction
Wim Bert Griet Schepens is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate the STING pathway. His work has implications for treating various diseases and disorders.
Latest Patents
Schepens holds a patent for "Cyclic dinucleotides as sting agonists." This patent discloses compounds, compositions, and methods for treating diseases, syndromes, or disorders that are affected by the modulation of STING. The compounds are represented by a specific formula, wherein various components are defined in detail.
Career Highlights
Wim Bert Griet Schepens is associated with Janssen Biotech, Inc., a company known for its innovative approaches in the pharmaceutical industry. His work at Janssen has allowed him to focus on groundbreaking research that can lead to new therapeutic options.
Collaborations
Some of his notable coworkers include Stuart Emanuel and Mark Richter. Their collaboration has likely contributed to the advancement of research and development in their respective fields.
Conclusion
Wim Bert Griet Schepens is a prominent figure in biotechnology, with a patent that showcases his innovative approach to treating diseases through the modulation of the STING pathway. His contributions continue to influence the field and hold promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile